Differential inflammatory macrophage response to rutile and titanium particles
-
Upload
independent -
Category
Documents
-
view
2 -
download
0
Transcript of Differential inflammatory macrophage response to rutile and titanium particles
ARTICLE IN PRESS
0142-9612/$ - se
doi:10.1016/j.bi
�CorrespondE-mail addr
Biomaterials 27 (2006) 5199–5211
www.elsevier.com/locate/biomaterials
Differential inflammatory macrophage response to rutileand titanium particles
Gema Vallesa, Pablo Gonzalez-Melendib, Jose L. Gonzalez-Carrascoc, Laura Saldanaa,Elena Sanchez-Sabatea, Luis Munuerad, Nuria Vilaboaa,�
aUnidad de Investigacion, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, SpainbCentro de Investigaciones Biologicas, CIB-CSIC, C/Ramiro de Maeztu 9, 28040 Madrid, Spain
cCentro Nacional de Investigaciones Metalurgicas, CENIM-CSIC, Avda. Gregorio del Amo 8, 28040 Madrid, SpaindDepartamento de Traumatologıa y Cirugıa Ortopedica, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain
Received 8 March 2006; accepted 29 May 2006
Available online 21 June 2006
Abstract
Titanium and its alloys are widely used as implant materials for dental and orthopaedic applications due to their advantageous bulk
mechanical properties and biocompatibility, compared to other metallic biomaterials. In order to improve their wear and corrosion
resistance, several surface modifications that give rise to an outer ceramic layer of rutile have been developed. The ability of rutile wear
debris to stimulate the release of inflammatory cytokines from macrophages has not been addressed to date. We have compared the in
vitro biocompatibility of sub-cytotoxic doses of rutile and titanium particles in THP-1 cells driven to the monocyte/macrophage
differentiation pathway as well as in primary cultures of human macrophages. Confocal microscopy experiments indicated that
differentiated THP-1 cells and primary macrophages efficiently internalised rutile and titanium particles. Treatment of THP-1 cells with
rutile particles stimulated the release of TNF-a, IL-6 and IL-1b to a lesser extent than titanium. The influence of osteoblasts on the
particle-induced stimulation of TNF-a and IL-1b was analysed by co-culturing differentiated THP-1 cells with human primary
osteoblasts. Under these conditions, secretion levels of both cytokines after treatment of THP-1 cells with rutile particles were lower than
after exposure to titanium. Finally, we observed that primary macrophages released higher amounts of TNF-a, IL-6 and IL-1b after
incubation with titanium particles than with rutile. Taken together, these data indicate that rutile particles are less bioreactive than
titanium particles and, therefore, a higher biocompatibility of titanium-based implants modified with an outer surface layer of rutile is
expected.
r 2006 Elsevier Ltd. All rights reserved.
Keywords: Osteolysis; Wear debris; Macrophage; Cytokine; Titanium; Titanium oxide
1. Introduction
The biological response to wear particles at the bone–implant interface is considered the main cause of asepticloosening and osteolysis [1,2]. Currently, the only clinicalintervention for aseptic loosening is implant revisionsurgery, and bone loss associated with this procedurelimits the number of times that it can be performed.Histological analysis of periprosthetic tissues retrievedfrom loose implants reveals the existence of a granuloma-
e front matter r 2006 Elsevier Ltd. All rights reserved.
omaterials.2006.05.045
ing author. Tel./fax: +34 912071034.
ess: [email protected] (N. Vilaboa).
tous membrane composed of numerous macrophages,fibroblasts, lymphocytes, giant cells, and wear particles[2–5]. Enlarged macrophages, often showing internalisedwear particles, were detected in these tissues [5–7].Biochemical and immunohistochemical analysis of peri-implant tissues from patients at revision indicated highlevels of cytokines known to stimulate bone resorption,such as interleukin-1b (IL-1b), interleukin-6 (IL-6) ortumor necrosis factor-a (TNF-a) [7–10]. Moreover, a highpercentage of macrophages in these tissues showedpositive staining for those cytokines [8,10]. In vivo and invitro experiments indicate that particulate debris withdiverse characteristics are phagocytosed by macrophages,
ARTICLE IN PRESSG. Valles et al. / Biomaterials 27 (2006) 5199–52115200
stimulating the secretion of the inflammatory cytokinesTNF-a or IL-1b [2]. These soluble factors act onosteoblasts inducing the expression of intercellular adhe-sion molecule-1 (ICAM-1), which mediates the recruitmentof osteoclast precursors, and receptor activator of NF-kBligand (RANKL), which stimulates the maturation andactivation of osteoclasts [11,12]. TNF-a and IL-1b alsostimulate osteoblastic IL-6 secretion, a potent activator ofbone resorption, which mediates their effects by stimulat-ing the secretion of RANKL [12]. In addition, TNF-a andIL-1b directly stimulate osteoclast differentiation andactivity through specific receptors expressed by cells ofthe osteoclast lineage [12]. Particles can also be internalisedby osteoblasts, stimulating the secretion of pro-resorptivefactors such as IL-6 and RANKL [13,14].
Titanium and Ti-based alloys are widely used for dentaland orthopaedic implants due to their good corrosionbehaviour and advantageous bulk mechanical properties,compared to other metallic biomaterials. The reduced ionrelease and excellent biocompatibility is largely attributedto the spontaneous formation of an inert surface passivefilm of non-stoichiometric TiO2, typically 4–6 nm thick,which is amorphous or poorly crystallized. However, metaldevices fail to integrate completely with the surroundingbone, whereby a thin fibrous layer forms at the bone–tissueinterface. Such a soft layer, under continuous mechanicalstress, is believed to initiate micromotions that give rise towear debris and favour the migration of macrophages tothe bone–implant interface. In fact, a significant number oftitanium particles have been detected in retrieval studiesof tissues surrounding failed implants [15,16]. The ability ofthese particles to stimulate focal bone resorption has beenwell established in vivo [14,17]. In vitro studies indicatethat titanium particles in the phagocytosable range are ableto induce macrophages to secrete osteolytic cytokines andinitiate an inflammatory response [18,19]. Increased thick-ness and crystallinity of the outside oxide layer of Ti-basedimplants can be obtained by treatments such as micro-arcoxidation or thermal oxidation [20–22]. These surfacemodifications not only improve corrosion resistance, butalso reduce the friction coefficient in rubbing contact. Theresulting rutile layer enhances osteoblast adhesion in vitro[23,24] and improves bone fixation in vivo [25]. Thus, thesemodified surfaces should limit the access of macrophagesand wear debris to the bone–implant interface. None-theless, functional loading for a long service period willlead to release of titanium oxide particles. In addition,rutile particles are increasingly proposed as reinforcementagents in the fabrication of composite materials [26], whichalso can suffer from particle loss.
To our knowledge, there is no information availablerelated to the inflammatory behaviour of macrophages inthe presence of rutile particles. In this work we haveevaluated the in vitro biocompatibility of these particles inTHP-1 cells differentiated to the monocyte–macrophagelineage as well as in human primary macrophages. To thisend, secretions of TNF-a, IL-6 and IL-1b were assessed in
cultures of both cell types after treatment with sub-cytotoxic doses of particles. For comparative purposes,titanium particles were used.
2. Materials and methods
2.1. Characterisation and preparation of particles
Rutile (TiO2) of 0.9–1.6mm-diameter and commercially pure titanium
(Ti) particles of o20 mm-diameter were obtained from Johnson Matthey
(Ward Hill, MA, USA). In order to characterise the morphology of the
materials, powders of the investigated particles were deposited on a
conductive and adhesive tape and then studied with scanning electron
microscopy (SEM) using a JEOL JSM 6500F (Jeol, Peabody, MA, USA).
Chemical composition of the particles was confirmed by electron
dispersive spectroscopy (EDS) using a Rontec EDR288 Software (Rontec,
Berlın, Germany). The equivalent circle diameter (ECD) was determined
by quantitative analysis of representative SEM images obtained from a
minimum of five different fields of view using the same magnifications.
Particle size analysis was performed with an Optimas Image Analyzer
equipped with SigmaScan Pro 4.0 Image Analysis Software (Jandel
Scientic Co., San Rafael, CA, USA). Particle characterisation was
completed by X-ray diffraction, confirming that TiO2 and Ti particles
were composed of rutile and pure titanium structures, respectively (data
not shown).
TiO2 and Ti particles were weighed and sterilised by incubation in
isopropanol at room temperature and dried under UV light in a laminar
flow hood. Prior to the addition to the cells, particles were re-suspended in
the appropriate culture medium (20mg/ml) and sonicated at maximum
power for 10min in a bath sonicator (Bransonic 12, Branson Ultrasonidos
S. A. E., Barcelona, Spain).
2.2. Cell culture and treatments
THP-1 cells (ECACC, Salisbury, Wiltshire, UK) were grown in RPMI-
1640 medium supplemented with 10% (v/v) heat-inactivated fetal bovine
serum (FBS), 500UI/ml of penicillin and 0.1mg/ml of streptomycin, in a
humidified 5% CO2 atmosphere at 37 1C. Cells were maintained in
continuous logarithmic growth by passage every 3 days. To induce
macrophage differentiation, cells were seeded into six-well plates at a
density of 2� 105 cells/well and continuously treated with 10 ng/ml 12-O-
tetradecanoyl phorbol 13-acetate (TPA) (Sigma, Madrid, Spain) for 36 h,
or treated only for 12 h and thoroughly washed with phosphate-buffered
saline (PBS) and incubated in fresh medium for a further 24 h. Then, cells
were washed with PBS and supplemented with 2ml of fresh medium.
Appropriate volumes of particle suspensions were added to cells to achieve
doses of 0.5, 5 and 50 ng/cell and cells were cultured for a further 24 h. As
controls, TPA-differentiated THP-1 cells were incubated in the absence of
particles.
Peripheral blood mononuclear cells (PBMC) were isolated from the
blood of healthy donors by differential centrifugation on Ficoll-Paque
Plus (Amersham Bioscience, Uppsala, Sweden). PBMC were seeded at a
density of 2� 106 cells/ml and cultured for 2 h in RPMI supplemented
with 2% heat-inactivated FBS and 500UI/ml of penicillin and 0.1mg/ml
of streptomycin. The medium was removed and adherent cells were
cultured in the same medium supplemented with 10% heat-inactivated
FBS. After 7 days, cells were harvested with 5mM EDTA in PBS and
plated in six-well plates at a density of 2� 105 cells/well for 24 h. PBMC
were washed with PBS and supplemented with 2ml of fresh medium.
Appropriate volumes of particle suspensions were added to cells to achieve
doses of 0.5, 5 and 50 ng/cell and cells were cultured for further 24 h. As
controls, PBMC were incubated in the absence of particles.
Human osteoblastic cells (OB) were derived from fresh trabecular bone
explants removed during total knee arthroplasty, as previously described
[23]. Bone samples were obtained from patients aged 6975 years old.
Patients enrolled in this research signed an Informed Consent form and all
ARTICLE IN PRESSG. Valles et al. / Biomaterials 27 (2006) 5199–5211 5201
procedures using human tissue designated ‘‘surgical waste’’ were approved
by the Human Research Committee of Hospital La Paz (Date of
Approval: 15 March 2001). Each bone sample was processed in a separate
primary culture and experiments were performed using cultures obtained
from independent patients. OB were cultured in Dulbecco0s modified
Eagle’s medium (DMEM) containing 15% (v/v) FBS, 100UI/ml penicillin
and 0.1mg/ml streptomycin in a humidified 5% CO2 atmosphere at 37 1C.
Culture medium was changed every 3 days until confluence was reached.
THP-1 and OB were co-cultured using a transwell insert system
(Corning, Life Sciences, MA, USA) that allows humoral contact of both
cell types, through a microporous membrane with a pore size of 0.4 mm,
without direct cell contact. 2� 105 THP-1 cells were seeded in six-well
plates and treated with 10 ng/ml TPA for 12 h, thoroughly washed with
PBS and cultured in fresh medium for 24 h. Parallel groups of 2� 105 OB
were seeded in inserts and cultured for 24 h. Then, THP-1 cells were
washed with PBS and supplemented with 3ml of a mixture of 50%
RPMI and 50% DMEM, containing 12.5% (v/v) heat-inactivated FBS,
500UI/ml of penicillin and 0.1mg/ml of streptomycin. Inserts containing
OB were washed with PBS and placed into the wells containing THP-1
cells. Appropriate volumes of particle suspensions were added to THP-1
cells to achieve doses of 50 ng/cell and co-cultures were incubated for
further 24 h. As controls, co-cultures of THP-1 and OB were subjected to
the same manipulations but incubated in the absence of particles.
2.3. Endotoxin test
Particles and culture media were endotoxin-free as demonstrated by the
Sigma E-TOXATE assay for detection and semi-quantification of
endotoxins (Sigma). Particles and culture media used in this study
contained levels of endotoxins below 0.015EU/ml.
2.4. Cytotoxicity assays
Lactate dehydrogenase (LDH) release was assayed with the Cyto Tox
96 (Promega, Madison, WI, USA), following the manufacturer’s
instructions.
2.5. Immunoenzymatic assays
Culture media were collected, filtered and centrifuged at 1200g for
10min, supplemented with a mixture of proteases inhibitors (17.5mg/ml
phenylmethylsulfonyl fluoride, 1mg/ml pepstatin A, 2 mg/ml aprotinin,
50 mg/ml bacitracin, all from Sigma) and frozen at �80 1C. Human-specific
ELISA kits were used to measure TNF-a (CLB, Amsterdam, Holland),
IL-6 and IL-1b (Biosource International Inc., Camarillo, CA, USA). The
detection limits of the kits were 1 pg/ml for TNF-a and IL-1b and 2 pg/ml
for IL-6. All procedures were performed following the manufacturer’s
instructions. The secreted levels were normalised to the total protein
amount, measured by the BCA protein assay (Pierce, Rockford, IL, USA),
using bovine serum albumin as standard.
2.6. Flow cytometry assays
Cell surface immuno-fluorescence staining was performed by incubat-
ing 1� 105 cells with fluorescein isothiocyanate (FITC)-conjugated anti-
human CD14 (Cymbus Biotechnology Ltd, Chandlers Ford, UK) for
30min at 4 1C in the dark. Cells incubated with FITC-conjugated mouse
inmunoglobulin G (Cymbus Biotechnology Ltd) were used as negative
controls. Cells were washed with PBS and fluorescence was measured by
flow cytometry using a FACSCalibur analyzer and CELLQUEST
software (both from Becton Dickinson Biosciences, San Jose, CA,
USA). For determination of CD11b antigen expression, 1� 105 cells were
incubated with 0.1mg/ml of human g-globulin in PBS for 15min at 4 1C in
the dark. Cells were washed with PBS and incubated with a mouse anti-
human CD11b (Becton Dickinson Biosciences) for 30min at 4 1C. Cells
incubated in the absence of CD11b were used as negative controls. Cells
were washed with PBS and incubated with FITC-conjugated anti-mouse
immunoglobulin G (Sigma) in PBS. Cells were washed with PBS and
fluorescence was measured by flow cytometry using the same equipment.
2.7. Confocal microscopy
Cells were seeded in eight-well chambers (Nunc, Wiesbaden, Germany)
(2� 104 cells/well) and cultured for 24 h in the presence or in the absence
of particles. Cells were extensively washed with PBS and fixed for 45min
with 2.5% glutaraldehyde in PBS, in darkness. Cells were washed with
PBS and mounted with a 1:1 mixture of glycerol/PBS; then a cover slip
was placed onto the specimen and sealed with nail varnish without
pressure. The specimens were observed in a confocal microscope (LEICA
TCS-SP2-AOBS, Leica microsystems, Heidelberg GMBH, Germany)
under a He/Ne laser (excitation lines 543 and 633 nm). The autofluorescent
signal of the biological samples due to glutaraldehyde fixation was
collected in the emission ranges 553–625nm and 675–753nm. The
presence of particles within the cells can be detected as non-fluorescent,
dark areas in an autofluorescent background, which were absent in the
untreated cells. Stacks of 0.5 mm optical sections spanning completed cells
were recorded and the confocal images were analysed using the LEICA
software LCS, version 2.5 Build 1227, which was also used for
morphometric analysis and measures of areas. Once we determined that
we had detected internalised rutile and Ti particles, we measured their
sizes. The areas of intracellular dark regions of different sizes were
measured using the same software, by manually outlining a region of
interest (ROI) on the projected maximum view of the confocal stack. The
software is calibrated with the original data from the confocal stack
collection in order to measure the real ROI area and therefore, calculate
the corresponding ECD. For each experimental condition, individual cells
were examined in order to determine the number of internalised particles/
cell. A significant number of measures were collected for each specimen.
2.8. Statistical analysis
The data are presented as mean7S.D. of several independent
experiments, each performed with an individual primary culture. Secretion
differences between isolated cultured and co-cultured cells as well as
characterisation of particles internalised into cells were analysed using
one-way analysis of variance (ANOVA) with Bonferroni0s correction for
post hoc comparisons. Two-way ANOVA for repeated measures were
performed for the rest of experiments. Post hoc comparisons were
analysed by 95% confidence interval adjusted by the Bonferroni’s method.
In all cases we confirmed results by non-parametric pair-wise Friedman’s
test with the appropriate post hoc comparisons. The p values o0.05 were
considered to be statistically significant. All statistical analyses were
performed using personal computer-based statistical software (SPSS
version 10.0.1; SPSS, Chicago, IL, USA).
3. Results
3.1. Characterisation of the particles
Morphological assessment of TiO2 particles showedthem to be globular with a grainy surface structure(Fig. 1(A)). Most of Ti particles were round with a smoothsurface, although the larger Ti particles were usuallyelongated and rough (Fig. 1(B)). The mean sizes of parti-cles were 0.4570.26 mm for TiO2 (range was 0.1–1.5 mm,92% were lower than 0.9 mm) and 3.3272.39 mm forTi (range was 1–15 mm, 89% were lower than 7 mm)(Figs. 1(A and B), respectively).
ARTICLE IN PRESS
0
5
10
15
20
25
30
ECD ( m)
Per
cen
tag
e fr
equ
ency
0.0
- 0.
1
0.1
- 0.
2
0.2
- 0.
3
1.6
- 1.
7
0.9
- 1.
0
0.3
- 0.
4
0.4
- 0.
5
0.5
- 0.
6
0.6
- 0.
7
0.7
- 0.
8
0.8
- 0.
9
1.0
- 1.
1
1.1
- 1.
2
1.2
- 1.
3
1.3
- 1.
4
1.4
- 1.
5
1.5
- 1.
6
0
5
10
15
20
25
30
ECD (
Per
cen
tag
e fr
equ
ency
0 -
1
1 -
2
2 -
3
16 -
17
9 -
10
3 -
4
4 -
5
5 -
6
6 -
7
7 -
8
8 -
9
10 -
11
11 -
12
12 -
13
13 -
14
14 -
15
15 -
16
m)
(A)
(B)
Fig. 1. Scanning electron microscopy images and particle size distribution of TiO2 (A) and Ti particles (B) (n ¼ 588).
G. Valles et al. / Biomaterials 27 (2006) 5199–52115202
3.2. Response of TPA-differentiated THP-1 cells to Ti or
TiO2 particles
TNF-a released from THP-1 cells at levels below thedetection limits of immunoenzymatic assays and treatmentof THP-1 cells with 50 ng/cell of Ti or TiO2 particles for24 h did not raise the secretion rates to detectable levels(Fig. 2(A)). THP-1 cells were incubated with 10 ng/ml TPAfor 36 h and then thoroughly washed and cultured in theabsence or presence of 50 ng/cell of particles for further24 h. TPA treatment of cells resulted in measurable levelsof TNF-a but incubation of TPA treated cells with Ti orTiO2 particles did not enhance the release of TNF-a to themedia (Fig. 2(A)). Parallel groups of THP-1 cells weretreated with TPA for only 12 h, washed and cultured infresh medium for 24 h, and then incubated in the absenceor in the presence of 50 ng/cell of particles for a further24 h. THP-1 cells treated with TPA for only 12 h secretedsubstantially lower amounts of TNF-a than the grouptreated continuously with the phorbol ester for 36 h andincubation with Ti or TiO2 particles increased TNF-a levels(Fig. 2(A)). Expression levels of the surface antigens CD14and CD11b, characteristics of the monocyte/macrophagelineage, increased to same extent in cells transiently treatedwith TPA for only 12 h or continuously for 36 h (Fig. 2(B)).Since treatment with TPA for only 12 h increased theexpression of differentiation markers and cells respondedto particles by releasing substantial amounts of TNF-a,subsequent experiments along this work were performedwith THP-1 cells differentiated according to this procedure.
3.3. Secretion of LDH after treatment of TPA-
differentiated THP-1 cells with Ti or TiO2 particles
Treatment of TPA-differentiated THP-1 cells with Ti orTiO2 particles for 24 h, at doses of 0.5, 5 or 50 ng/cell, didnot result in a significant increase of LDH release, ascompared to the levels detected in media from untreatedTPA-differentiated cells (Fig. 3).
3.4. Internalisation of Ti and TiO2 particles
In order to assess if the particles were internalised intoTPA-differentiated THP-1 cells, we used confocal micro-scopy. The cells were fixed in a solution of glutaraldehyde,which provides an autofluorescence background to theoverall cell structure where the presence of the particlescan be inferred by the absence of staining. We first noticeda dose-dependent effect of the particles in the cells. At0.5 ng/cell of TiO2 or Ti, some dark areas of differentsizes were observed on projections of 3D confocal stacks(Figs. 4(A and D)); the dark areas were larger and moreevident at a concentration of 5 ng/cell (Figs. 4(B and E)).At the highest tested dose, an increasing number of largedark areas were observed (Figs. 4(C and F)). The 3Dposition of these dark areas was determined by analysingorthogonal sections along the planes XZ and YZ acrossparticular, small, dark areas visualised in the confocalstack. When the stack was virtually sectioned along the XZ
plane (bottom panel) and the YZ plane (right panel), weobserved that the dark area penetrated inside the cell and
ARTICLE IN PRESS
&
1
2
3
4
5
0
12h, rec 24h36 h
Ti
#
+-
N.D. N.D.
TPA -
12h, rec 24h36 h
70.74 %CONTROL
CD14
71.98 %CONTROL
CD14
TPA -
Fluorescence (log)
100
30
0
120
90
150
60
5.47 %CONTROL
101 102 103 104
Fluorescence (log)
100 101 102 103 104
Fluorescence (log)
100 101 102 103 104
Fluorescence (log)
100 101 102 103 104
Fluorescence (log)
100 101 102 103 104
Fluorescence (log)
100 101 102 103 104
Cel
l nu
mb
er
30
0
120
90
150
60
Cel
l nu
mb
er
30
0
120
90
150
60
Cel
l nu
mb
er
30
0
120
90
150
60
Cel
l nu
mb
er
30
0
120
90
150
60
Cel
l nu
mb
er
30
0
120
90
150
60
Cel
l nu
mb
er
CD14
12h, rec 24h36 h
73.83 %CONTROL
CD11b
71.28 %CONTROL
CD11b
TPA -
CONTROL
CD11b
36.69 %
N.D.
-
TiO2 - - +
+- -
- - +
+- -
- - +
*
(A)
(B)
Fig. 2. Response of TPA-differentiated THP-1 cells to Ti or TiO2 particles. THP-1 cells were cultured in the absence of TPA (�), with TPA for 36 h, or for
12 h and then cultured for 24 h in fresh medium (12 h, rec 24 h). (A) TNF-a secretion from THP-1 cells after treatment with Ti or TiO2 particles. Untreated
or TPA-treated cells were incubated in the absence (�) or in the presence (+) of 50 ng/cell of Ti or TiO2 particles for 24 h. The data are relative to the level
of TNF-a measured in media from THP-1 cells treated with TPA for 12 h, cultured in fresh medium and not exposed to particles (0.5170.06 pg TNF-a/mgtotal proteins), which was given the arbitrary value of 1. Each value represents the mean7S.D. of six independent experiments. *po0:05 compared to
TPA (12 h, rec 24 h) not exposed to particles; #po0:05 compared to TPA (36 h); &po0:05 compared to treatment with TiO2 particles in TPA (12 h, rec
24 h). N.D.: Not detected. (B) Flow cytometric determination of the expression of the surface markers CD14 and CD11b in THP-1 cells untreated or
treated with TPA. The grey dashed lines indicate the boundary for the positive staining.
G. Valles et al. / Biomaterials 27 (2006) 5199–5211 5203
ARTICLE IN PRESSR
elat
ive
LD
H r
elea
se
0.0
0.5
1.0
1.5
0.5 5 50
ng /cell
Fig. 3. LDH release in TPA-differentiated THP-1 cells after treatment
with particles. Cells were untreated or treated with the indicated doses of
TiO2 ( ) or Ti ( ) particles for 24 h. The data are relative to the
absorbance measured in untreated cells, which was given the arbitrary
value of 1. Each value represents the mean7S.D. of six independent
experiments.
G. Valles et al. / Biomaterials 27 (2006) 5199–52115204
showed a three-dimensional arrangement. Images corre-sponding to cells treated with the intermediate doses(5 ng/cell) of TiO2 (Fig. 4(H)) and Ti (Fig. 4(I)) are shown.Fig. 4(G) shows orthogonal sections of untreated culturesof TPA-differentiated THP-1 cells, without any dark areasinside. The size of the dark areas inside the cells wasmeasured by manually outlining their contour in the 3Dstacks, using the image processing software of the confocalmicroscope. The distribution of areas vs. their relativefrequencies was represented in histograms as shown inFigs. 4(J and K) for TiO2 and Ti particles, respectively.Average size of particles was smaller in cells exposed toTiO2 than to Ti particles. However, the number ofparticles/cell was higher for TiO2 than for Ti particles(Table 1).
3.5. Secretion of TNF-a, IL-6 and IL-1b from TPA-
differentiated THP-1 cells treated with Ti or TiO2 particles
Treatment of TPA-differentiated THP-1 cells with Tiparticles at any tested dose for 24 h stimulated the secretionof TNF-a and IL-6 (po0:05) (Figs. 5(A and B)). Levels ofboth cytokines in media from cells treated with 5 ng/cell ofparticles were higher than those measured in media fromcells treated with 0.5 ng/cell (po0:05). The highest testeddose did not enhance the released amounts of thesecytokines above levels detected in media from cells treatedwith 5 ng/cell of Ti particles. Incubation with TiO2 particlesresulted in a dose-dependent significant increase of TNF-aand IL-6 secretion (po0:05). TiO2 particles at 0.5 and5 ng/cells resulted in lower TNF-a and IL-6 levels thanthose measured after treatment with the corresponding
doses of Ti. At the highest dose, TiO2 particles stimulatedsecretion of TNF-a at lower extent than Ti although nosignificant differences were observed in levels of IL-6.Finally, levels of IL-1b also increased in a dose-dependentmanner in the media of cells treated with Ti or TiO2
particles (po0:05), but the levels were substantially lowerin cells treated with TiO2 particles at any tested dose(Fig. 5(C)).
3.6. Secretion of TNF-a and IL-1b from co-cultures of OB
and TPA-differentiated THP-1 cells treated with Ti or TiO2
particles
We wondered about the ability of OB to modulate,through secretion of soluble factors, the TiO2 and Tiparticles-induced TNF-a and IL-1b secretion in TPA-differentiated THP-1 cells. To this end, these cells were co-cultured with OB without direct cell contact and incubatedfor 24 h in the absence or presence of 50 ng/cell of Ti orTiO2 particles. For comparative purposes, media fromisolated cultured OB or THP-1 cells, incubated in theabsence of particles, were also evaluated. TNF-a and IL-1bwere not detected in the media from isolated cultured OB(Figs. 6(A and B)). Compared to the amounts released byisolated cultured THP-1 cells, co-culturing of THP-1 cellswith OB diminished or abolished the secretion of TNF-aand IL-1b, respectively. Treatment of co-cultured THP-1cells with Ti particles increased the levels of both cytokines.TiO2 particles only increased IL-1b release and comparedto incubation with Ti, secretion levels were significantlylower.
3.7. Secretion of LDH and internalisation assays after
treatment of human primary macrophages with Ti and TiO2
particles
The human primary macrophages cultures containedmore than 85% CD14-positive cells as determined by flowcytometry (Fig. 7(A)). Treatment of macrophages with Tior TiO2 particles for 24 h, at doses of 0.5, 5 or 50 ng/cell,did not result in significant increase of LDH release, ascompared to the levels detected in media from untreatedmacrophages (Fig. 7(B)).Internalisation of the particles into the cells was assessed
by confocal microscopy. As observed in THP-1 cells, wenoticed a dose-dependent effect of the particles (datanot shown). After exposure to 5 ng particles/cell of TiO2
(Fig. 7(D)) and Ti (Fig. 7(E)) for 24 h, we observed somesmall, dark areas of different sizes in the cells in 3D stacks,which were not detected in untreated cells (Fig. 7(C)). The3D position of these unstained regions in the cells wasdetermined by virtual sectioning of the stack along the XZ
(bottom panels in Figs. 7(C, D and E)) and YZ planes(right panels in Figs. 7(C, D and E)) at the central point ofthese areas (arrows in central panels). Observation of theseorthogonal sections showed that the particles are locatedinside the cells (arrows in side-panels of Figs. 7(D and E)).
ARTICLE IN PRESS
0
5
10
15
20
25
ECD (µm)
Per
cen
tag
e fr
equ
ency
0 -
1
1 -
2
2 -
3
9 -
10
3 -
4
4 -
5
5 -
6
6 -
7
7 -
8
8 -
9
10 -
11
11 -
12
12 -
13
13 -
14
14 -
15
15 -
16
30
35
Per
cen
tag
e fr
equ
ency
0.0
- 0.
5
0.5
- 1.
0
4.0
- 4.
5
1.0
- 1.
5
1.5
- 2.
0
2.0
- 2.
5
2.5
- 3.
0
3.0
- 3.
5
3.5
- 4.
0
4.5
- 5.
0
0
5
10
15
20
25
30
35
ECD (µm)
(A) (B) (C)
(F)(E)(D)
(G)
(J) (K)
(H) (I)
Fig. 4. Internalisation of particles into TPA-differentiated THP-1 cells. (A–F) Cells were treated for 24 h with TiO2 or Ti particles at doses of 0.5 ng/cell (A
or D), 5 ng/cell (B or E) and 50 ng/cell (C or F). (G–I) Orthogonal projections along the XZ (bottom panels) and YZ (right panels) at a random position of
untreated cells (G) or at a central position of unstained areas of cells treated with 5 ng/cell of TiO2 (H) or Ti particles (I). Bars ¼ 40 mm. (J,K) Size
distribution of internalised particles in cells treated with 5 ng/cell of TiO2 (J) or Ti (K) particles (n ¼ 63).
Table 1
Characterization of particles internalized in TPA-differentiated THP-1 cells and human primary macrophages
TPA-differentiated THP-1 cells Human primary macrophages
TiO2 Ti TiO2 Ti
ECD (mm) 2.2670.86* 5.0472.55 1.9070.96 3.9271.99
Particles/cell 1975* 973 1474** 1272
ECD and number of particles/cell into cells treated with TiO2 or Ti particles. *po0:05 compared to Ti particles in TPA-differentiated THP-1 cells;
**po0:05 compared to TiO2 particles in TPA-differentiated THP-1 cells.
G. Valles et al. / Biomaterials 27 (2006) 5199–5211 5205
No dark areas inside the cells were observed on orthogonalprojections of the untreated controls (Fig. 7(C)). The sizeof these dark areas inside the cells was measured by
manually outlining their contour in the 3D stacks and thedistribution of areas vs. their relative frequencies wasrepresented in histograms as shown in Figs. 7(F and G) for
ARTICLE IN PRESS
0
1
2
3
4
5
Rel
ativ
e T
NF
-α s
ecre
tio
n
0.5 5 50
ng /cell
ng /cell
ng /cell
*
*
*
0
1
2
3
4
5
Rel
ativ
e IL
-6 s
ecre
tio
n
0.5 5 50
*
*
150
250
50
024
152535
0.5 5 50
Rel
ativ
e IL
-1β
secr
etio
n
*
*
*
(A) (B)
(C)
Fig. 5. TNF-a (A), IL-6 (B) and IL-1b (C) secretion in TPA-differentiated THP-1 cells treated with particles. Cells were untreated or treated with the
indicated doses of TiO2 ( ) or Ti ( ) particles for 24 h. The data are relative to cytokines levels measured in untreated cells, which were given the arbitrary
value of 1. Untreated cells released 0.5170.06 pg TNF-a/mg total proteins, 1.5570.13 pg IL-6/mg total proteins and 0.3470.07 pg IL-1b/mg total proteins.
Each value represents the mean7S.D. of six independent experiments. *po0:05 compared to treatment with Ti particles, at the corresponding tested dose.
G. Valles et al. / Biomaterials 27 (2006) 5199–52115206
TiO2 and Ti particles, respectively. Average sizes andnumber of particles/cell were similar in cells treated withTiO2 or Ti (Table 1).
3.8. Secretion of TNF-a, IL-6 and IL-1b from human
primary macrophages treated with Ti or TiO2 particles
Treatment of macrophages with Ti particles at 0.5, 5 or50 ng/cell for 24 h resulted in a dose-dependent inductionof TNF-a (po0:05). While secreted levels of TNF-aincreased by about 30 fold after treatment with Ti particlesat 0.5 ng/cell and to 250 fold after treatment with thehighest tested dose, TiO2 particles at 0.5 or 5 ng/cell onlystimulated the secretion of this cytokine by about 2-fold(Fig. 8(A)). After treatment with the highest tested dose ofTiO2 particles, macrophages secreted similar levels ofTNF-a to untreated cells. Similar behaviour was observedafter evaluation of released IL-6 after treatments with bothtypes of particles. Treatment with Ti particles resulted in adose-dependent induction of IL-6 (po0:05), which in-creased by 200 fold after treatment with 50 ng/cell of thistype of particle, while TiO2 treatment marginally affectedthe released levels of IL-6 (Fig. 8(B)). Untreated humanprimary macrophages released IL-1b at levels below thedetection limit of the immunoenzymatic assay and we only
could detect this cytokine after treatment with Ti or TiO2
particles at 50 ng/cell. At this dose, TiO2 particlesstimulated macrophages to release significantly lower levelsof IL-1b than Ti particles (Fig. 8(C)).
4. Discussion
The THP-1 cell line is a useful in vitro model forstudying the wear response to particles in macrophages. Todrive these cells along the monocytic/macrophage differ-entiation pathway, several inducers such as the active formof vitamin D3 (1a, 25 dihydroxyvitamin D3) or the phorbolester TPA have been employed [27,28]. Examination ofphagocytosis ability and expression of the surface markersCD14 and CD11b indicate that TPA treatment results in amore differentiated phenotype than treatment with 1a, 25dihydroxyvitamin D3 [29]. However, TPA differentiationalso stimulates the release of substantial amounts ofinflammatory cytokines such as TNF-a, IL-1b, IL-6 orprostaglandin E2 (PGE2) [29–31]. Results from this workindicate that neither Ti particles, which are recognised tostimulate the release of inflammatory cytokines in macro-phages [18,19], nor rutile particles enhanced the secretionof TNF-a when applied to continuously TPA-treatedTHP-1 cells. Transient application of the phorbol ester
ARTICLE IN PRESSR
elat
ive
TN
F-α
sec
reti
on
Rel
ativ
e IL
-1β
secr
etio
n
-
THP-1 THP-1
OB
THP-1
OB
2.0
0.0
1.0
3.0
* #
N.D.
OB
-
2
10
8
6
4
0
-
THP-1 THP-1
OB
THP-1
OBOB
-
N.D.N.D.
* &
&
+
+
*
(A)
(B)
Fig. 6. TNF-a (A) or IL-1b (B) secretion in TPA-differentiated THP-1
cells co-cultured with OB. Levels of both cytokines were determined in
cultures of TPA-differentiated THP-1 cells ( ), OB, or co-cultures of OB
and TPA-differentiated THP-1 cells untreated ( ) or treated with
50 ng/cell of TiO2 ( ) or Ti ( ) particles for 24 h. The data are relative
to cytokines levels measured in TPA-differentiated THP-1 cells, which
were given the arbitrary value of 1. Untreated cells released 0.5170.06 pg
TNF-a/mg total proteins and 0.3470.07 pg IL-1b/mg total proteins. Each
value represents the mean7S.D. of five independent experiments.
*po0:05 compared to TPA-differentiated THP-1 cells; #po0:05 compared
to co-cultures treated with Ti particles; &po0:05 compared to treatment
with TiO2 particles. (�) indicates the absence of the corresponding cell
type; (+) indicates that co-cultured TPA-differentiated THP-1 cells were
treated with 50 ng/cell of TiO2 or Ti particles. N.D.: Not detected.
G. Valles et al. / Biomaterials 27 (2006) 5199–5211 5207
drove cells to an equivalent maturation stage to thatachieved by continuous treatment, according to theexpression levels of CD14 and CD11b antigens. Ti andrutile particles stimulated the secretion of TNF-a, IL-6 andIL-1b by cells transiently treated with TPA, indicating thatthis is a suitable method for studying the inflammatoryresponse to particles. Moreover, the behaviour of thesecells after treatment with Ti or rutile particles followedsimilar trends to those observed in human primarymacrophages under the same experimental conditions.
Internalisation of wear particles into cultured cells hasbeen examined using several microscopy techniques.Among these, confocal and transmission electron micro-scopy are more sensitive than the visualisation of particlesunder phase contrast on a light microscope. Only confocalor physical sectioning of the specimens permits theidentification of particles internalised into cells. Althoughobservation of ultra-thin sections on the electron micro-scope allows a direct visualisation of mineral particlesbecause they are dense to the electrons [32], this procedureis more time-consuming and requires higher technical skillsthan confocal microscopy, which in turn allows definitionof the intracellular location where the particles arecontained as the absence of intracellular staining in afluorescence background. To this aim, confocal microscopymakes use of specific dyes such as phalloidin staining toreveal the actin network [33], or general dyes, such asacridine orange [34]. In this work, we have developed aone-step technical advance to visualise rutile and Tiparticles by taking advantage of the autofluorescenceproperties of glutaraldehyde, one of the most commonlyused fixatives for microscopy studies. Together withoptimal preservation of the cell’s structure, this offerssatisfactory and reproducible results while avoiding addi-tional staining, washing and further manipulation of thespecimens. Phalloidin staining leaves non-stained spacescorresponding to the position of the cell’s organelles, whichmakes the identification of internalised particles difficult,while treatment with glutaraldehyde extensively crosslinkscellular proteins and provides an autofluorescence signal tothe overall cell structure. Thus, the non-stained areascorrespond to a non-biological composition. On the otherhand, the resolution of the confocal microscopy, 0.2 mm inthe XY plane, was enough to detect the size of particlesused in this study. The location of rutile and Ti particleswas inferred by the presence of small, dark areas ofdifferent sizes, which correspond to a non-biologicalnature, in the autofluorescent cells. The 3D position ofthe particles was determined by virtually sectioning thestack across the XZ and YZ planes at a given position,finding that the particles were unequivocally internalisedinto the cells. A dose-dependent effect was observed: thehigher the dose, the more and larger the dark areas. 3Dconfocal stacks are amenable to morphometric studies bymeasuring the areas of manually outlined ROIs usingsuitable software, such as the one we employed in this work[35]. Mean sizes of Ti and rutile particles internalised byboth THP-1 cells and primary macrophages were higherthan the mean sizes of the powders of particles used in thisstudy, indicating the existence of aggregates of particlesinside the cells. Together with the work of others reportingthe agglomeration of alumina and titania particles inculture media [36], our results suggest that cells mayinternalise aggregates rather than individual particles. Indespite that the mean size of dry rutile particles was about7 fold lower than that of dry Ti, intracellular aggregates ofrutile and Ti presented similar dimensions. Interestingly,
ARTICLE IN PRESS
Rel
ativ
e L
DH
rel
ease
0.0
0.5
1.0
1.5
0.5 5 50
ng /cellFluorescence (log)
100
5
0
20
15
25
10
101 102 103 104
Cel
l nu
mb
er
0
5
10
15
20
25
Per
cen
tag
e fr
equ
ency
0.0
- 0.
5
0.5
- 1.
0
1.0
- 1.
5
5.0
- 5.
5
1.5
- 2.
0
2.0
- 2.
5
2.5
- 3.
0
3.0
- 3.
5
3.5
- 4.
0
4.0
- 4.
5
5.5
- 6.
0
30
35
40
0
5
10
15
20
25
Per
cen
tag
e fr
equ
ency
0 -
1
1 -
2
2 -
3
9 -
10
3 -
4
4 -
5
5 -
6
6 -
7
7 -
8
8 -
9
10 -
11
11 -
12
12 -
13
30
35
40
30
87.50 %CONTROL
CD14
ECD (µm) ECD (µm)
(A) (B)
(C)
(F) (G)
(D) (E)
Fig. 7. Response of human primary macrophages to particles. (A) Flow cytometric determination of the surface marker CD14 expression. The grey
dashed lines indicate the boundary for the positive staining. (B) LDH release in cultures of macrophages after treatment with particles. Cells were
untreated or treated with the indicated doses of TiO2 ( ) or Ti ( ) particles for 24 h. The data are relative to the absorbance measured in untreated cells,
which was given the arbitrary value of 1. Each value represents the mean7S.D. of eight independent experiments. (C–E) Orthogonal projections along the
XZ (bottom panels) and YZ (right panels) at a random position in untreated cells (C) or at a central position of unstained areas of cells treated with
5 ng/cell of TiO2 (D) or Ti particles (E). Bars ¼ 40mm. (F,G) Size distribution of internalised particles in cells treated with 5 ng/cell of TiO2 (F) or Ti (G)
particles (n ¼ 63).
G. Valles et al. / Biomaterials 27 (2006) 5199–52115208
titania particles of 4 mm diameter also aggregated in theculture media to the same extent as alumina particles of0.17 mm [36].
Chemistry of the particles influences their ability tostimulate an inflammatory response in macrophages[37,38]. In agreement with several reports addressing theinflammatory potential of Ti particles [18,19], levels ofTNF-a, IL-6 and IL-1b raised in culture media of THP-1cells treated with this type of particle. Rutile particles alsostimulated their release, but to a lesser extent than Tiparticles, suggesting the better biocompatibility of rutile. Inthis regard, it has been shown that other ceramic particles,such as Al2O3 or ZrO2, induce a lower release of TNF-athan Ti particles in THP-1 cells differentiated with 1a, 25dihydroxyvitamin D3 and granulocyte-macrophage colony-
stimulating factor (GM-CSF) [39]. Particles of sub-micro-meter size are more effective inducers of macrophageactivation than those of larger size [40,41]. Consequently,levels of secreted cytokines after treatment with rutileparticles should be expected to be higher than afterexposure to Ti particles. The opposite effect we havedetected supports the higher biocompatibility of rutile,compared with Ti debris.Co-cultures of osteoblasts and macrophages have proven
to be a valuable tool for studying interactions betweenthese types of cells in the presence of wear particles [42–45].Co-cultures of differentiated THP-1 cells and humanprimary osteoblasts, in the absence of particles, decreasedthe levels of secreted TNF-a or IL-1b by THP-1 cells. Theinfluence of osteoblasts to modulate TNF-a secretion by
ARTICLE IN PRESS
0.5 5 50
Rel
ativ
e IL
-6 s
ecre
tio
n
0
4
8
10
30
50
200
300
* * *
0.0
0.1
0.2
0.3
0.4
0.5IL
-1β
secr
etio
n (
pg
/µg
pro
t)
0.5 5 50
N.D.N.D.
*
Rel
ativ
e T
NF
-α s
ecre
tio
n
0.5 5 50 ng /cell ng /cell
ng /cell
210
3
30
40
250
450
50
* **
(A) (B)
(C)
Fig. 8. TNF-a (A), IL-6 (B) and IL-1b (C) secretion in human primary macrophages treated with particles. Cells were untreated or treated with the
indicated doses of TiO2 ( ) or Ti ( ) particles for 24 h. The data corresponding to TNF-a and IL-6 are relative to cytokines levels measured in untreated
cells, which were given the arbitrary value of 1. Untreated cells released 0.1270.30 pg TNF-a/mg total proteins and 3.3570.53 pg IL-6/mg total proteins.
Each value represents the mean7S.D. of six independent experiments. *po0:05 compared to treatment with Ti particles in C and *po0:001 in A and B, at
the corresponding tested dose. N.D.: Not detected.
G. Valles et al. / Biomaterials 27 (2006) 5199–5211 5209
macrophages has been previously detected in other co-culture models [42,44] and in this work we have detectedthat IL-1b secretion is also regulated. Particles modulatethe secretion of cytokines typically involved in boneturnover in co-cultures of osteoblasts and macrophages[42–45]. In contrast to Ti, in our co-culture experiments,rutile particles were not able to influence the secretion ofTNF-a and stimulated IL-1b release to a lower extent. Tiparticles enhanced the release of TNF-a in a co-culturemodel of J774.A1 and MC3T3-E1 cells, but polymethyl-methacrylate particles failed to regulate its production [43],proving that the chemistry of the particles stronglyinfluences the interactions of macrophages and osteoblasts.Compared to Ti, attenuation in the levels of TNF-a andIL-1b after treatment of co-cultured macrophage-like cellswith rutile particles predicts their lower bioreactivity, asboth cytokines play a relevant role in the initiation of theinflammatory response to wear debris [2,19].
Finally, we studied the behaviour of human primarymacrophages treated with Ti and rutile particles. As inTHP-1 cultures, both types of particles were efficientlyinternalised by these cells without eliciting a harmfulresponse, as determined by release of LDH to the media.Inductions of TNF-a, IL-6 and IL-1b after treatment withTi particles were much higher in human primary macro-
phages than in differentiated THP-1 cells. These resultsconcur with earlier observations indicating that Ti particlesmore efficiently stimulate the levels of IL-1 in mouseprimary macrophages than in murine cell lines P388D1 orIC-21 [46]. Interestingly, treatment of human primarymacrophages with Ti particles released much higher levelsof TNF-a, IL-6 and IL-1b than rutile, which only margin-ally stimulated the levels of these cytokines.In summary, the data in this work indicate that,
compared with Ti, rutile particles induce a lower responsein vitro, defined as their ability to induce TNF-a, IL-6 andIL-1b secretion in macrophages cultures of differentsources. Ti-based surfaces modified to create an outerlayer of rutile show improved corrosion [21] and wearresistance [22]. We provide now evidence that rutile debrisare less prone to initiate a inflammatory response than Tiparticles, accounting for the better biocompatibility of thiskind of surfaces.
5. Conclusions
In this study we have comparatively analysed theinflammatory potential of rutile and titanium particles ofphagocytosable size. Confocal microscopy experimentsrevealed that both types of particles were efficiently
ARTICLE IN PRESSG. Valles et al. / Biomaterials 27 (2006) 5199–52115210
internalised in cultures of TPA-differentiated THP-1 cellsas well as in primary cultures of human macrophages.Rutile particles stimulated the release of TNF-a, IL-6 andIL-1b to a lesser extent than titanium particles in thesecellular models. Compared to treatment with titaniumparticles, TNF-a and IL-1b were also released to a lesserextent in co-cultures of human osteoblasts and TPA-differentiated cells treated with rutile particles. Theseresults support the higher biocompatibility of titanium-based implants modified to create an outer layer of rutileon their surfaces.
Acknowledgements
This work was supported by grants from CICYTMAT2001/0019/CO2/O1-O2 from the Spanish Ministryof Science and Technology, FIS PI03/0036 from Fondo deInvestigaciones Sanitarias and Fundacion Mutua Madri-lena. NV is supported by Grant award FIS 01/3027 fromthe Fondo de Investigaciones Sanitarias. P G-M is fundedby the programme ‘‘Ramon y Cajal’’ of the SpanishMinistry of Education and Science. We thank MarıaAngeles Ollacarizqueta and Marıa Teresa Seisdedos, of theconfocal microscopy service of the Centro de Investiga-ciones Biologicas (CIB, CSIC) for excellent technicalsupport. The authors thank the medical staff of the Ortho-paedic Department and Haematology Service (HospitalLa Paz, Madrid, Spain) for providing us with bone andblood samples.
References
[1] Jacobs JJ, Roebuck KA, Archibeck M, Hallab NJ, Glant TT.
Osteolysis: basic science. Clin Orthop Rel Res 2001;393:71–7.
[2] Ingham E, Fisher J. The role of macrophages in osteolysis of total
joint replacement. Biomaterials 2005;26:1271–86.
[3] Perry MJ, Mortuza FY, Ponsford FM, Elson CJ, Atkins RM.
Analysis of cell types and mediator production from tissues around
loosening joint implants. Br J Rheumatol 1995;34:1127–34.
[4] Goodman SB, Huie P, Song Y, Schurman D, Maloney W, Woolson
S, et al. Cellular profile and cytokine production at prosthetic
interfaces. Study of tissues retrieved from revised hip and knee
replacements. J Bone Joint Surg Br 1998;80:531–9.
[5] Hatton A, Nevelos JE, Nevelos AA, Banks RE, Fisher J, Ingham E.
Alumina-alumina artificial hip joints. Part I: a histological analysis
and characterisation of wear debris by laser capture microdissection
of tissues retrieved at revision. Biomaterials 2002;23:3429–40.
[6] Watkins SC, Macaulay W, Turner D, Kang R, Rubash HE, Evans
CH. Identification of inducible nitric oxide synthase in human
macrophages surrounding loosened hip prostheses. Am J Pathol
1997;150:1199–206.
[7] Kim KJ, Chiba J, Rubash HE. In vivo and in vitro analysis of
membranes from hip prostheses inserted without cement. J Bone
Joint Surg Am 1994;76:172–80.
[8] Jones LC, Frondoza C, Hungerford DS. Immunohistochemical
evaluation of interface membranes from failed cemented and
uncemented acetabular components. J Biomed Mater Res 1999;48:
889–98.
[9] Chiba J, Schwendeman LJ, Booth Jr RE, Crossett LS, Rubash HE. A
biochemical, histologic, and immunohistologic analysis of mem-
branes obtained from failed cemented and cementless total knee
arthroplasty. Clin Orthop Relat Res 1994;299:114–24.
[10] Park YS, Moon YW, Lim SJ, Yang JM, Ahn G, Choi YL. Early
osteolysis following second-generation metal-on-metal hip replace-
ment. J Bone Joint Surg Am 2005;87:1515–21.
[11] Tanaka Y, Nakayamada S, Okada Y. Osteoblasts and osteoclasts in
bone remodeling and inflammation. Curr Drug Targets Inflamm
Allergy 2005;4:325–8.
[12] Kwan TS, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6,
RANKL, TNF-a/IL-1: interrelations in bone resorption pathophy-
siology. Cytokine Growth Factor Rev 2004;15:49–60.
[13] Vermes C, Chandrasekaran R, Jacobs JJ, Galante JO, Roebuck KA,
Glant TT. The effects of particulate wear debris, cytokines, and
growth factors on the functions of MG-63 osteoblasts. J Bone Joint
Surg Am 2001;83:201–11.
[14] Choi MG, Koh HS, Kluess D, O0Connor D, Mathur A, Truskey GA,
et al. Effects of titanium particle size on osteoblasts functions in vitro
and in vivo. Proc Natl Acad Sci USA 2005;102:4578–83.
[15] Buly RL, Huo MH, Salvati EA, Brien W, Bansal M. Titanium wear
debris in failed cemented total hip arthroplasty: an analysis of 71
cases. J Arthroplasty 1992;7:315–23.
[16] Margevicius KJ, Bauer TW, Mc Mahon JT, Brown SA, Merritt K.
Isolation and characterization of debris in membranes around total
joint prostheses. J Bone Joint Surg Am 1994;76:1664–75.
[17] Warme BA, Epstein NJ, Trindade MCD, Miyanishi K, Ma T, Saket
RR, et al. Proinflammatory mediator expression in a novel murine
model of titanium-particle-induced intramedullary inflammation.
J Biomed Mater Res B 2004;71:360–6.
[18] Schwarz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, et
al. Tumor necrosis factor-a/nuclear transcription (factor-kappaB)
signaling in periprosthetic osteolisis. J Orthop Res 2000;18:472–80.
[19] Rader CP, Sterner T, Jakob F, Schutze N, Eulert J. Cytokine
response of human macrophage-like cells after contact with
polyethylene and pure titanium particles. J Arthroplasty 1999;14:
840–8.
[20] Han Y, Xu KW. Photoexcited formation of bone apatite-like
coatings on micro-arc oxidized titanium. J Biomed Mater Res 2004;
71A:608–14.
[21] Garcıa-Alonso MC, Saldana L, Valles G, Gonzalez-Carrasco JL,
Cabrero J, Martınez ME, et al. In vitro corrosion behaviour
and osteoblast response of thermally oxidised Ti6Al4V alloy. Bio-
materials 2003;24:19–26.
[22] Guleryuz H, Cimenoglu H. Effect of thermal oxidation on corrosion
and corrosion-wear behaviour of a Ti6Al4V alloy. Biomaterials 2004;
25:3325–33.
[23] Saldana L, Vilaboa N, Valles G, Gonzalez-Cabrero J, Munuera L.
Osteoblast response to thermally oxidized Ti6Al4V alloy. J Biomed
Mater Res A 2005;73:97–107.
[24] Feng B, Weng J, Yang BC, Qu SX, Zhang XD. Characterization of
surface oxide films on titanium and adhesion of osteoblast.
Biomaterials 2003;24:4663–70.
[25] Li LH, Kong YM, Kim HW, Kim YW, Kim HE, Heo SJ, et al.
Improved biological performance of Ti implants due to surface
modification by micro-arc oxidation. Biomaterials 2004;25:2867–75.
[26] von Walter M, Ruger M, Ragosse C, Steffens GC, Hollander DA,
Paar O, et al. In vitro behavior of a porous TiO2/perlite composite
and its surface modification with fibronectin. Biomaterials 2005;26:
2813–26.
[27] Cutolo M, Carruba G, Villaggio B, Coviello DA, Dayer JM, Campisi
I, et al. Phorbol diester 12-O-tetradecanoylphorbol 13-acetate (TPA)
up-regulates the expression of estrogen receptors in human THP-1
leukemia cells. J Cell Biochem 2001;83:390–400.
[28] Auwerx J. The human leukemia cell line, THP-1: a multifacetted
model for the study of monocyte-macrophage differentiation.
Experientia 1991;47:22–31.
[29] Schwende H, Fitzke E, Ambs P, Dieter P. Differences in the state
of differentiation of THP-1 cells induced by phorbol ester and
1,25-dihydroxyvitamin D3. J Leukoc Biol 1996;59:555–61.
[30] Smith CJ, Morrow JD, Roberts 2nd LJ, Marnett LJ. Induction of
prostaglandin endoperoxide synthase-1 (COX-1) in a human
ARTICLE IN PRESSG. Valles et al. / Biomaterials 27 (2006) 5199–5211 5211
promonocytic cell line by treatment with the differentiating agent
TPA. Adv Exp Med Biol 1997;400A:99–106.
[31] Meier CA, Chicheportiche R, Juge-Aubry CE, Dreyer MG, Dayer
JM. Regulation of the interleukin-1 receptor antagonist in THP-1
cells by ligands of the peroxisome proliferator-activated receptor
gamma. Cytokine 2002;18:320–8.
[32] Lohmann CH, Schwartz Z, Koster G, Jahn U, Buchhorn GH,
MacDougall MJ, et al. Phagocytosis of wear debris by osteo-
blasts affects differentiation and local factor production in a
manner dependent on particle composition. Biomaterials 2000;21:
551–61.
[33] Wang ML, Nesti LJ, Tuli R, Lazatin J, Danielson KG, Sharkey PF,
et al. Titanium particles suppress expression of osteoblastic pheno-
type in human mesenchymal stem cells. J Orthop Res 2002;20:
1175–84.
[34] Bi Y, Collier TO, Goldberg VM, Anderson JM, Greenfield EM.
Adherent endotoxin mediates biological responses of titanium
particles without stimulating their phagocytosis. J Orthop Res 2002;
20:696–703.
[35] Gonzalez-Melendi P, Ramırez C, Kumlehn J, Testillano PS,
Risueno MC. 3D confocal and electron microscopy imaging
define the dynamics and mechanisms of diploidisation at early
stages of barley microspore-derived embryogenesis. Planta 2005;222:
47–57.
[36] Gutwein LG, Webster TJ. Increased viable osteoblast density in the
presence of nanophase compared to conventional alumina and titania
particles. Biomaterials 2004;25:4175–83.
[37] Petit A, Catelas I, Antoniou J, Zukor DJ, Huk OL. Differen-
tial apoptotic response of J774 macrophages to alumina and ultra-
high-molecular-weight polyethylene particles. J Orthop Res 2002;20:
9–15.
[38] Haynes DR, Boyle SJ, Rogers SD, Howie DW, Vernon-Roberts B.
Variation in cytokines induced by particles from different prosthetic
materials. Clin Orthop Relat Res 1998;352:223–30.
[39] Sterner T, Schutze N, Saxler G, Jakob F, Rader CP. Effects of
clinically relevant alumina ceramic, zirconia ceramic and titanium
particles of different sizes and concentrations on TNF-a release in a
human macrophage cell line. Biomed Tech (Berl) 2004;49:340–4.
[40] Mitchell W, Matthews JB, Stone MH, Fisher J, Ingham E.
Comparison of the response of human peripheral blood mononuclear
cells to challenge with particles of three bone cements in vitro.
Biomaterials 2003;24:737–48.
[41] Matthews JB, Besong AA, Green TR, Stone MH, Wroblewski BM,
Fisher J, et al. Evaluation of the response of primary human
peripheral blood mononuclear phagocytes to challenge with in vitro
generated clinically relevant UHMWPE particles of known size and
dose. J Biomed Mater Res 2000;52:296–307.
[42] Rodrigo A, Valles G, Saldana L, Rodriguez M, Martınez ME,
Munuera L, et al. Alumina particles influence the interactions of
cocultured osteoblasts and macrophages. J Orthop Res 2006;24:46–54.
[43] Horowitz SM, Gonzales JB. Inflammatory response to implant
particulates in a macrophage/osteoblast coculture model. Calcif
Tissue Int 1996;59:392–6.
[44] Horowitz SM, Luchetti WT, Gonzales JB, Ritchie CK. The effects of
cobalt chromium upon macrophages. J Biomed Mater Res 1998;41:
468–73.
[45] Attawia MA, Nicholson JJ, Laurencin CT. Coculture system to
assess biocompatibility of candidate orthopaedic materials. Clin
Orthop Rel Res 1999;365:230–8.
[46] Glant TT, Jacobs JJ. Response of three murine macrophage
populations to particulate debris: bone resorption in organ cultures.
J Orthop Res 1994;12:720–31.